Illustration of the Management and Prognosis of Japanese Patients with Cardiac Sarcoidosis by Multimodality Imaging and Genetic Analysis

Illustration of the Management and Prognosis of Japanese Patients with Cardiac Sarcoidosis by Multimodality Imaging and Genetic Analysis - ILLUMINATE-CS Imaging

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053948

Enrollment

550

Registered

2024-04-01

Start date

2024-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Sarcoidosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients newly diagnosed as cardiac sarcoidosis from January 1st, 2001 to December 31st, 2017. 2. Diagnosis of cardiac sarcoidosis is according to either Japanese Circulation Society (JCS) criteria proposed in 2016 or the Heart Rhythm Society (HRS) 2014 consensus statement modified at the J Am Coll Cardiol 2016 (Birnie DH, et al. J Am Coll Cardiol 2016;68:411-21) 3. Patients who provided informed consent are eligible for genetic analysis.

Exclusion criteria

Exclusion criteria: 1. Patients without sufficient information for this study 2. Patients who contact persons judge as ineligible for this study

Design outcomes

Primary

Measure	Time frame
Composite of all-cause death, hospitalization for heart failure, and documented fatal ventricular arrhythmia events (VT/VF).	—

Secondary

Measure	Time frame
1. All-cause death 2. Sustained VT, VF, or appropriate ICD/CRT-D therapy 3. Non-sustained VT or appropriate ICD/CRT-D therapy 4. Hospitalization for Heart failure 5. Advanced atrioventricular block, complete atrioventricular block 6. Cardiac devices implantation (pacemaker, ICD, CRT) 7. Catheter ablation 8. Immunosuppressant therapy	—

Countries

Japan

Contacts

Public ContactTadao Aikawa

Juntendo University Graduate School of Medicine Department of Cardiovascular Biology and Medicine

tadao.aikawa@juntendo.ac.jp03-3813-3111

Outcome results